KURA
Price
$7.81
Change
-$0.26 (-3.22%)
Updated
Aug 29, 04:06 PM (EDT)
Capitalization
700.45M
62 days until earnings call
PTCHF
Price
$1.82
Change
+$0.03 (+1.68%)
Updated
Aug 27 closing price
Capitalization
435.82M
Interact to see
Advertisement

KURA vs PTCHF

Header iconKURA vs PTCHF Comparison
Open Charts KURA vs PTCHFBanner chart's image
Kura Oncology
Price$7.81
Change-$0.26 (-3.22%)
Volume$6.63K
Capitalization700.45M
PureTech Health
Price$1.82
Change+$0.03 (+1.68%)
Volume$7.72K
Capitalization435.82M
KURA vs PTCHF Comparison Chart in %
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KURA vs. PTCHF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Buy and PTCHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (KURA: $8.07 vs. PTCHF: $1.82)
Brand notoriety: KURA and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 200% vs. PTCHF: 75%
Market capitalization -- KURA: $700.45M vs. PTCHF: $435.82M
KURA [@Biotechnology] is valued at $700.45M. PTCHF’s [@Biotechnology] market capitalization is $435.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whilePTCHF’s FA Score has 0 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • PTCHF’s FA Score: 0 green, 5 red.
According to our system of comparison, KURA is a better buy in the long-term than PTCHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 5 TA indicator(s) are bullish while PTCHF’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 5 bullish, 4 bearish.
  • PTCHF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PTCHF is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а +8.47% price change this week, while PTCHF (@Biotechnology) price change was +1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.98%. For the same industry, the average monthly price growth was +15.18%, and the average quarterly price growth was +29.51%.

Reported Earning Dates

KURA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($700M) has a higher market cap than PTCHF($436M). KURA YTD gains are higher at: -7.348 vs. PTCHF (-9.000). PTCHF has higher annual earnings (EBITDA): -53.65M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. PTCHF (502M). KURA has less debt than PTCHF: KURA (19.5M) vs PTCHF (24M). KURA has higher revenues than PTCHF: KURA (83.3M) vs PTCHF (0).
KURAPTCHFKURA / PTCHF
Capitalization700M436M161%
EBITDA-192.46M-53.65M359%
Gain YTD-7.348-9.00082%
P/E RatioN/A10.71-
Revenue83.3M0-
Total Cash631M502M126%
Total Debt19.5M24M81%
FUNDAMENTALS RATINGS
KURA vs PTCHF: Fundamental Ratings
KURA
PTCHF
OUTLOOK RATING
1..100
2489
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4556
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (27) in the Biotechnology industry is in the same range as PTCHF (49) in the null industry. This means that KURA’s stock grew similarly to PTCHF’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTCHF (100) in the null industry. This means that KURA’s stock grew similarly to PTCHF’s over the last 12 months.

KURA's SMR Rating (100) in the Biotechnology industry is in the same range as PTCHF (100) in the null industry. This means that KURA’s stock grew similarly to PTCHF’s over the last 12 months.

KURA's Price Growth Rating (45) in the Biotechnology industry is in the same range as PTCHF (56) in the null industry. This means that KURA’s stock grew similarly to PTCHF’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PTCHF (100) in the null industry. This means that KURA’s stock grew similarly to PTCHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURAPTCHF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALABX12.910.03
+0.20%
ALPS/Smith Balanced Opportunity A
GEGTX84.37N/A
N/A
Columbia Large Cap Growth Inst
FICHX14.46N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl Inst
WFENX14.74N/A
N/A
Allspring International Equity Inst
IOAPX30.59N/A
N/A
Invesco Main Street All Cap R6

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and KURA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
KURA - PTCHF
30%
Poorly correlated
+2.67%
PRTC - PTCHF
30%
Poorly correlated
-3.66%
STTK - PTCHF
24%
Poorly correlated
-0.71%
LYEL - PTCHF
23%
Poorly correlated
-1.60%
BCTX - PTCHF
22%
Poorly correlated
-3.95%
More